Table 2 Denomination and prevalence of multimorbidity patterns found in COVID-19 patients based on sex and age and their age-adjusted odds ratios (aOR) of infection severity compared with chronic patients without multimorbidity.
15–64 years | 65–79 years | ≥ 80 years | ||||
|---|---|---|---|---|---|---|
Pattern name (N, prevalence %) | Severity aOR (95% CI) | Pattern name (N, prevalence %) | Severity aOR (95% CI) | Pattern name (N, prevalence %) | Severity aOR (95% CI) | |
Women | Cardiometabolic (4,205, 21.4%) | 1.85 (1.43–2.41) | Cardiometabolic (673, 19.1%) (99% diabetes mellitus) | 1.97 (1.15–3.49) | Cardiometabolic (541, 13.1%) | 1.29 (0.85–1.96) |
Menstrual-dysphoric (2,204, 11.1%) | 1.48 (1.08–2.02) | Thyroid-cardiometabolic (515, 14.6%) (no diabetes mellitus) | 1.55 (0.86–2.79) | Psychogeriatric (1,011, 24.5%) | 1.06 (0.71–1.58) | |
Mental health (2,046, 10.3%) | 0.90 (0.63–1.29) | Osteoporotic-cardiovascular (70, 19.9%) (no diabetes mellitus) | 1.20 (0.67–2.14) | Mental health (753, 18.3%) | 1.32 (0.87–1.98) | |
Upper respiratory (1,987, 10.0%) | 1.13 (0.79–1.62) | Mental health (823, 23.3%) (no diabetes mellitus) | 1.58 (0.90–2.80) | Non-specific (1,679, 40.8%) | 1.05 (0.71–1.55) | |
Non-specific (4,810, 24.3%) | 1.35 (1.02–1.77) | Non-specific (663, 18.8%) (no diabetes mellitus) | 1.22 (0.68.2.18) | |||
Control group (4,528, 22.8%) | Control group (152, 4.3%) | Control group (135, 3.3%) | ||||
Men | Hypertension-obesity (1,585, 10.4%) | 1.60 (1.25–2.05) | Cardiometabolic I (421, 12.3%) (99% obesity) | 1.76 (1.18–2.62) | Cardiometabolic I (546, 24.6%) | 1.28 (0.96–1.70) |
Cardiometabolic (1,136, 7.4%) | 1.43 (1.14–1.80) | Cardiometabolic II (619, 18.1%) (no obesity) | 1.23 (0.84–1.81) | Cardiometabolic II (590, 26.5%) | 1.28 (0.96–1.70) | |
Mental Health (1,911, 12.5%) | 1.35 (1.06–1.74) | Cardiometabolic III (637, 18.6%) (no obesity) | 1.41 (0.96–2.06) | Arthrosis-cardiometabolic (444, 20.0%) | 1.28 (0.96–1.71) | |
Upper respiratory (1,446, 9.5%) | 1.30 (0.97–1.75) | Prostatic-cardiometabolic (699, 20.4%) (18% obesity) | 1.30 (0.89–1.89) | Prostatic (233, 10.5%) | 1.30 (0.92–1.84) | |
Headache (1,949, 12.8%) | 1.24 (0.93–1.64) | Arthrosis-cardiometabolic (394, 11.5%) (no obesity) | 1.20 (0.80–1.82) | Dementia (348, 15.6%) | 1.42 (1.04–1.94) | |
Non-specific (2,274, 14.9%) | 1.18 (1.03–1.60) | Non-specific (416, 12.1%) (no obesity) | 1.28 (0.85–1.93) | |||
Control group (4,973, 32.6%) | Control group (241, 7.0%) | Control group (63, 2.8%) | ||||
